the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model. Blood 114, 5322-5330.
Ward, T., Pipkin, P.A., Clarkson, N.A., Stone, D., Minor, P.D., and Almond, J.W. (1994). Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO J. 75, 5070-5074.
Weber, F., Wagner, V., Rasmussen, S.B., Hartmann, R., and Paludan, S.R. (2006). Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80, 5059-5064.
Wherry, E.J. (2011). T celi exhaustion. Nat. Immunol. 12, 492-499.
Whitt, M.A. (2010). Generation of VSV pseudotypes using recombinant [Delta]G-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines. J. Virol. Methods 169, 365-374.
Williams, B.R. (1999). PKR; a sentinel kinase for cellular stress. Oncogene 18, 6112-6120.
Willnow, T.E. (1999). The low-density lipoprotein receptor gene family: multiple roles in lipid metabolism. J. Mol. Med. 77, 306-315.
Wolchok, J.D., Kluger, H., Callahan, M.K., Postow, M.A., Rizvi, N.A., Lesokhin, A.M., Segal, N.H., Ariyan, C.E., Gordon, R.-A., Reed, K., et al. (2013). Nivolumab plus Ipilimumab in advanced melanoma. N. Engl. J. Med.
Wollmann, G., Rogulin, V., Simon, I., Rosę, J.K., and van den Pol, A.N. (2010). Some Attenuated Variants of Vesicular Stomatitis Virus Show Enhanced Oncolytic Activity against Human Glioblastoma Cells relative to Normal Brain Cells. J. Virol. 84, 1563-1573.
Wongthida, P., Diaz, R.M., Galivo, F., Kottke, T., Thompson, J., Melcher, A., and Vile, R. (2010a). VSV oncolytic virotherapy in the BI6 model depends upon intact MyD88 signaling. Mol. Ther.
Wongthida, P., Diaz, R.M., Galivo, F., Kottke, T., Thompson, J., Pulido, J., Pavelko, K., Pease, L., Melcher, A., and Vile, R. (201 Ob). Type 111 1FN interleukin-28 mediates the antitumor efficacy of oncolytic virus VSV in immune-competent mouse models of cancer. Cancer Res. 70, 4539-4549.
Wongthida, P., Diaz, R.M., Pulido, C., Rommelfanger, D., Galivo, F., Kałuża, K., Kottke, T., Thompson, J., Melcher, A., and Vile, R. (2011). Activating systemie T-cell immunity
221